- Home
- Publications
- Publication Search
- Publication Details
Title
Adjuvant Chemotherapy in Elderly Colorectal Cancer Patients
Authors
Keywords
-
Journal
Cancers
Volume 12, Issue 8, Pages 2289
Publisher
MDPI AG
Online
2020-08-14
DOI
10.3390/cancers12082289
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evaluation of the Change of Outcomes over a Ten-Year Period in Patients with Stage III Colon Cancer: Pooled Analysis of 6501 Patients Treated with Fluorouracil, Leucovorin, and Oxaliplatin in the ACCENT Database
- (2020) M.E. Salem et al. ANNALS OF ONCOLOGY
- Beyond the NCCN Risk Factors in Colon Cancer: An Evaluation in a Swedish Population-Based Cohort
- (2020) Erik Osterman et al. ANNALS OF SURGICAL ONCOLOGY
- Adjuvant chemotherapy in patients with colorectal cancer. Is there a role in the older adult?
- (2020) Demetris Papamichael et al. EJSO
- Adjuvant chemotherapy for locally advanced rectal cancer in elderly patients after neoadjuvant chemoradiotherapy and surgery
- (2020) Quanquan Sun et al. MEDICINE
- Adjuvant chemotherapy in rectal cancer
- (2020) Bengt Glimelius CURRENT OPINION IN ONCOLOGY
- Guidelines for time-to-event end-point definitions in adjuvant randomised trials for patients with localised colon cancer: Results of the DATECAN initiative
- (2020) Romain Cohen et al. EUROPEAN JOURNAL OF CANCER
- Short-course radiotherapy followed by chemotherapy before TME in locally advanced rectal cancer: The randomized RAPIDO trial.
- (2020) Geke Hospers et al. JOURNAL OF CLINICAL ONCOLOGY
- Adjuvant chemotherapy in patients with rectal cancer achieving pathologic complete response after neoadjuvant chemoradiation and surgery
- (2019) Gianluca Tomasello et al. EUROPEAN JOURNAL OF CANCER
- Adjuvant chemotherapy for rectal cancer with complete pathological response (pCR) may not be necessary: a pooled analysis of 5491 patients
- (2019) Xiang Hu et al. Cancer Cell International
- FOxTROT: an international randomised controlled trial in 1052 patients (pts) evaluating neoadjuvant chemotherapy (NAC) for colon cancer.
- (2019) Matthew T. Seymour et al. JOURNAL OF CLINICAL ONCOLOGY
- Emerging trends in the treatment of rectal cancer
- (2019) Bruce D. Minsky ACTA ONCOLOGICA
- Long-course preoperative chemoradiation versus 5 × 5 Gy and consolidation chemotherapy for clinical T4 and fixed clinical T3 rectal cancer: long-term results of the randomized Polish II study
- (2019) B Ciseł et al. ANNALS OF ONCOLOGY
- Determining the use of preoperative (chemo)radiotherapy in primary rectal cancer according to national and international guidelines
- (2019) Klara Hammarström et al. RADIOTHERAPY AND ONCOLOGY
- Compliance to Adjuvant Chemotherapy of Patients Who Underwent Surgery for Rectal Cancer: Report from a Multi-institutional Research Network
- (2019) Giulio M. Mari et al. WORLD JOURNAL OF SURGERY
- Association between Preoperative Pelvic Irradiation and Toxicity of Subsequent Chemotherapy in Rectal Cancer
- (2019) Mateusz Spałek et al. Oncology Research and Treatment
- Randomized controlled trial of 8 weeks versus 12 weeks interval between neoadjuvant chemotherapy and surgery for locally advanced rectal cancer
- (2019) Cem Terzi et al. Colorectal Disease
- Neoadjuvant Modified FOLFOX6 With or Without Radiation Versus Fluorouracil Plus Radiation for Locally Advanced Rectal Cancer: Final Results of the Chinese FOWARC Trial
- (2019) Yanhong Deng et al. JOURNAL OF CLINICAL ONCOLOGY
- The 2017 Assisi Think Tank Meeting on rectal cancer: A positioning paper
- (2019) Vincenzo Valentini et al. RADIOTHERAPY AND ONCOLOGY
- Treatment selection bias for chemotherapy persists in colorectal cancer patient cohort studies even in comprehensive propensity score analyses
- (2019) Daniel Boakye et al. Clinical Epidemiology
- Can less be more? Organ preservation strategies in the management of rectal cancer
- (2019) F. Rouleau-Fournier et al. Current Oncology
- Oxaliplatin-Based Adjuvant Chemotherapy for Rectal Cancer After Preoperative Chemoradiotherapy (ADORE): Long-Term Results of a Randomized Controlled Trial
- (2019) Yong Sang Hong et al. JOURNAL OF CLINICAL ONCOLOGY
- Use of Neoadjuvant Chemotherapy in the Treatment of Locally Advanced Rectal Cancer
- (2019) Katherine Y. Hu et al. JOURNAL OF SURGICAL RESEARCH
- Improved survival with adjuvant chemotherapy in locally advanced rectal cancer patients treated with preoperative chemoradiation regardless of pathologic response
- (2019) John V. Gahagan et al. SURGICAL ONCOLOGY-OXFORD
- Oncological outcome after MRI-based selection for neoadjuvant chemoradiotherapy in the OCUM Rectal Cancer Trial
- (2018) R. Ruppert et al. BRITISH JOURNAL OF SURGERY
- FOLFOX or CAPOX in Stage II to III Colon Cancer: Efficacy Results of the Italian Three or Six Colon Adjuvant Trial
- (2018) Alberto Sobrero et al. JOURNAL OF CLINICAL ONCOLOGY
- Delay in Adjuvant Chemotherapy and Survival Advantage in Stage III Colon Cancer
- (2018) Megan C. Turner et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- 3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial
- (2018) Timothy J Iveson et al. LANCET ONCOLOGY
- Duration of Adjuvant Chemotherapy for Stage III Colon Cancer
- (2018) Axel Grothey et al. NEW ENGLAND JOURNAL OF MEDICINE
- Treatment of Elderly Patients with Colorectal Cancer
- (2018) Yoshiro Itatani et al. Biomed Research International
- Association of Adjuvant Chemotherapy With Overall Survival in Patients With Rectal Cancer and Pathologic Complete Response Following Neoadjuvant Chemotherapy and Resection
- (2018) Patricio M. Polanco et al. JAMA Oncology
- Recurrence Risk After Up-to-Date Colon Cancer Staging, Surgery, and Pathology
- (2018) Erik Osterman et al. DISEASES OF THE COLON & RECTUM
- Preoperative chemoradiotherapy and postoperative chemotherapy with capecitabine +/- oxaliplatin in locally advanced rectal cancer: Final results of PETACC-6.
- (2018) Hans-Joachim Schmoll et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of age, gender, and performance status (PS) on the duration results of adjuvant chemotherapy for stage III colon cancer: The IDEA collaboration.
- (2018) Anthony Frank Shields et al. JOURNAL OF CLINICAL ONCOLOGY
- Frailty status but not age predicts complications in elderly cancer patients: a follow-up study
- (2018) Marianne Ørum et al. ACTA ONCOLOGICA
- Is adjuvant chemotherapy necessary for locally advanced rectal cancer patients with pathological complete response after neoadjuvant chemoradiotherapy and radical surgery? A systematic review and meta-analysis
- (2018) Bin Ma et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- Comparative proteogenomic analysis of right-sided colon cancer, left-sided colon cancer and rectal cancer reveals distinct mutational profiles
- (2018) Robin Imperial et al. Molecular Cancer
- Influence of age and comorbidity on prognosis and application of adjuvant chemotherapy in elderly Japanese patients with colorectal cancer: A retrospective multicentre study
- (2017) Tomoki Yamano et al. EUROPEAN JOURNAL OF CANCER
- Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer
- (2017) Toshiaki Watanabe et al. International Journal of Clinical Oncology
- Challenges behind proving efficacy of adjuvant chemotherapy after preoperative chemoradiation for rectal cancer
- (2017) Carlos Carvalho et al. LANCET ONCOLOGY
- Optimal fractionation of preoperative radiotherapy and timing to surgery for rectal cancer (Stockholm III): a multicentre, randomised, non-blinded, phase 3, non-inferiority trial
- (2017) Johan Erlandsson et al. LANCET ONCOLOGY
- Impact of venous invasion on the efficacy of adjuvant chemotherapy in elderly patients with stage III colorectal cancer
- (2017) Nobuaki Hoshino et al. MEDICAL ONCOLOGY
- Geriatric Assessment Predicts Survival and Competing Mortality in Elderly Patients with Early Colorectal Cancer: Can It Help in Adjuvant Therapy Decision‐Making?
- (2017) Maite Antonio et al. ONCOLOGIST
- On a prolonged interval between rectal cancer (chemo)radiotherapy and surgery
- (2017) Bengt Glimelius UPSALA JOURNAL OF MEDICAL SCIENCES
- Long-course oxaliplatin-based preoperative chemoradiation versus 5 × 5 Gy and consolidation chemotherapy for cT4 or fixed cT3 rectal cancer: results of a randomized phase III study
- (2016) K. Bujko et al. ANNALS OF ONCOLOGY
- Adjuvant systemic chemotherapy for stages II and III colon cancer after complete resection: a clinical practice guideline
- (2016) B.M. Meyers et al. Current Oncology
- PRODIGE 34 – FFCD 1402 – ADAGE
- (2016) Thomas Aparicio et al. DIGESTIVE AND LIVER DISEASE
- Determining the Optimal Timing for Initiation of Adjuvant Chemotherapy After Resection for Stage II and III Colon Cancer
- (2016) Zhifei Sun et al. DISEASES OF THE COLON & RECTUM
- Intensity of adjuvant chemotherapy regimens and grade III–V toxicities among elderly stage III colon cancer patients
- (2016) F.N. van Erning et al. EUROPEAN JOURNAL OF CANCER
- Global patterns and trends in colorectal cancer incidence and mortality
- (2016) Melina Arnold et al. GUT
- Recurrence-free and overall survival among elderly stage III colon cancer patients treated with CAPOX or capecitabine monotherapy
- (2016) F.N. van Erning et al. INTERNATIONAL JOURNAL OF CANCER
- Should the Benefit of Adjuvant Chemotherapy in Colon Cancer Be Re-Evaluated?
- (2016) Lars A. Påhlman et al. JOURNAL OF CLINICAL ONCOLOGY
- Two countries – Two treatment strategies for rectal cancer
- (2016) Bengt Glimelius et al. RADIOTHERAPY AND ONCOLOGY
- Validity of Adjuvant! Online in older patients with stage III colon cancer based on 2967 patients from the ACCENT database
- (2016) Demetris Papamichael et al. Journal of Geriatric Oncology
- Review on adjuvant chemotherapy for rectal cancer – why do treatment guidelines differ so much?
- (2015) Laurids Ø. Poulsen et al. ACTA ONCOLOGICA
- Impact of age and medical comorbidity on adjuvant treatment outcomes for stage III colon cancer: a pooled analysis of individual patient data from four randomized, controlled trials
- (2015) D. G. Haller et al. ANNALS OF ONCOLOGY
- Survival following early-stage colon cancer: an ACCENT-based comparison of patients versus a matched international general population
- (2015) L. A. Renfro et al. ANNALS OF ONCOLOGY
- Effect of Delay in Adjuvant Oxaliplatin-Based Chemotherapy for Stage III Colon Cancer
- (2015) Renata D'Alpino Peixoto et al. Clinical Colorectal Cancer
- Tumour characteristics, treatment patterns and survival of patients aged 80 years or older with colorectal cancer
- (2015) K. Kotake et al. Colorectal Disease
- Postoperative chemotherapy in patients with rectal cancer receiving preoperative radio(chemo)therapy: A meta-analysis of randomized trials comparing surgery ± a fluoropyrimidine and surgery + a fluoropyrimidine ± oxaliplatin
- (2015) K. Bujko et al. EJSO
- Improved survival with early adjuvant chemotherapy after colonic resection for stage III colonic cancer: A nationwide study
- (2015) Mads Klein et al. JOURNAL OF SURGICAL ONCOLOGY
- Adjuvant chemotherapy after preoperative (chemo)radiotherapy and surgery for patients with rectal cancer: a systematic review and meta-analysis of individual patient data
- (2015) Anne J Breugom et al. LANCET ONCOLOGY
- Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial
- (2015) Claus Rödel et al. LANCET ONCOLOGY
- Chemotherapy for colorectal cancer in the elderly
- (2015) Jung Han Kim WORLD JOURNAL OF GASTROENTEROLOGY
- Treatment of colorectal cancer in the elderly
- (2015) Monica Millan et al. World Journal of Gastrointestinal Oncology
- Risk of recurrence in patients with colon cancer stage II and III: A systematic review and meta-analysis of recent literature
- (2014) Camilla Böckelman et al. ACTA ONCOLOGICA
- Chronicle: results of a randomised phase III trial in locally advanced rectal cancer after neoadjuvant chemoradiation randomising postoperative adjuvant capecitabine plus oxaliplatin (XELOX) versus control
- (2014) R. Glynne-Jones et al. ANNALS OF ONCOLOGY
- S-1 as adjuvant chemotherapy for stage III colon cancer: a randomized phase III study (ACTS-CC trial)
- (2014) M. Yoshida et al. ANNALS OF ONCOLOGY
- Treatment of colorectal cancer in older patients: International Society of Geriatric Oncology (SIOG) consensus recommendations 2013
- (2014) D. Papamichael et al. ANNALS OF ONCOLOGY
- The impact of low-grade toxicity in older people with cancer undergoing chemotherapy
- (2014) T Kalsi et al. BRITISH JOURNAL OF CANCER
- Randomised phase III trial of adjuvant chemotherapy with oral uracil and tegafur plus leucovorin versus intravenous fluorouracil and levofolinate in patients with stage III colorectal cancer who have undergone Japanese D2/D3 lymph node dissection: Final results of JCOG0205
- (2014) Yasuhiro Shimada et al. EUROPEAN JOURNAL OF CANCER
- Adjuvant chemotherapy in rectal cancer: Defining subgroups who may benefit after neoadjuvant chemoradiation and resection: A pooled analysis of 3,313 patients
- (2014) Monique Maas et al. INTERNATIONAL JOURNAL OF CANCER
- A systematic review and meta-analysis of adjuvant chemotherapy after neoadjuvant treatment and surgery for rectal cancer
- (2014) Fausto Petrelli et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- Capecitabine and Oxaliplatin in the Preoperative Multimodality Treatment of Rectal Cancer: Surgical End Points From National Surgical Adjuvant Breast and Bowel Project Trial R-04
- (2014) Michael J. O'Connell et al. JOURNAL OF CLINICAL ONCOLOGY
- International Society of Geriatric Oncology Consensus on Geriatric Assessment in Older Patients With Cancer
- (2014) Hans Wildiers et al. JOURNAL OF CLINICAL ONCOLOGY
- ACCENT-Based Web Calculators to Predict Recurrence and Overall Survival in Stage III Colon Cancer
- (2014) Lindsay A. Renfro et al. JNCI-Journal of the National Cancer Institute
- Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial
- (2014) Julien Taieb et al. LANCET ONCOLOGY
- The effect of a geriatric evaluation on treatment decisions for older cancer patients – a systematic review
- (2013) Marije E. Hamaker et al. ACTA ONCOLOGICA
- Reduced risk of distant recurrence after adjuvant chemotherapy in patients with stage III colon cancer aged 75 years or older
- (2013) F. N. van Erning et al. ANNALS OF ONCOLOGY
- Short-course radiotherapy followed by neo-adjuvant chemotherapy in locally advanced rectal cancer – the RAPIDO trial
- (2013) Per J Nilsson et al. BMC CANCER
- Context-dependent interpretation of the prognostic value of BRAF and KRAS mutations in colorectal cancer
- (2013) Vlad Popovici et al. BMC CANCER
- Impact of Age on the Efficacy of Newer Adjuvant Therapies in Patients With Stage II/III Colon Cancer: Findings From the ACCENT Database
- (2013) Nadine J. McCleary et al. JOURNAL OF CLINICAL ONCOLOGY
- Comparison of Outcomes After Fluorouracil-Based Adjuvant Therapy for Stages II and III Colon Cancer Between 1978 to 1995 and 1996 to 2007: Evidence of Stage Migration From the ACCENT Database
- (2013) Qian Shi et al. JOURNAL OF CLINICAL ONCOLOGY
- Microsatellite Instability and BRAF Mutation Testing in Colorectal Cancer Prognostication
- (2013) Paul Lochhead et al. JNCI-Journal of the National Cancer Institute
- Relative Effectiveness and Safety of Chemotherapy in Elderly and Nonelderly Patients With Stage III Colon Cancer: A Systematic Review
- (2013) A. Hung et al. ONCOLOGIST
- Treatment and complications in elderly stage III colon cancer patients in the Netherlands
- (2012) K. W. J. Hoeben et al. ANNALS OF ONCOLOGY
- Patients with rectal cancer receiving adjuvant chemotherapy have an increased survival: a population-based longitudinal study
- (2012) C. Tiselius et al. ANNALS OF ONCOLOGY
- ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making
- (2012) H. J. Schmoll et al. ANNALS OF ONCOLOGY
- Deficient mismatch repair phenotype is a prognostic factor for colorectal cancer in elderly patients
- (2012) Thomas Aparicio et al. DIGESTIVE AND LIVER DISEASE
- Adjuvant Therapy With Fluorouracil and Oxaliplatin in Stage II and Elderly Patients (between ages 70 and 75 years) With Colon Cancer: Subgroup Analyses of the Multicenter International Study of Oxaliplatin, Fluorouracil, and Leucovorin in the Adjuvant Treatment of Colon Cancer Trial
- (2012) Christophe Tournigand et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of Adjuvant Chemotherapy on Survival of Patients With Stage III Colon Cancer Diagnosed After Age 75 Years
- (2012) Hanna K. Sanoff et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical Outcome of the ACCORD 12/0405 PRODIGE 2 Randomized Trial in Rectal Cancer
- (2012) Jean-Pierre Gérard et al. JOURNAL OF CLINICAL ONCOLOGY
- Comparative Effectiveness of Oxaliplatin vs Non–Oxaliplatin-containing Adjuvant Chemotherapy for Stage III Colon Cancer
- (2012) Hanna K. Sanoff et al. JNCI-Journal of the National Cancer Institute
- Capecitabine versus 5-fluorouracil/folinic acid as adjuvant therapy for stage III colon cancer: final results from the X-ACT trial with analysis by age and preliminary evidence of a pharmacodynamic marker of efficacy
- (2011) C. Twelves et al. ANNALS OF ONCOLOGY
- Oxaliplatin As Adjuvant Therapy for Colon Cancer: Updated Results of NSABP C-07 Trial, Including Survival and Subset Analyses
- (2011) Greg Yothers et al. JOURNAL OF CLINICAL ONCOLOGY
- Value of Mismatch Repair, KRAS, and BRAF Mutations in Predicting Recurrence and Benefits From Chemotherapy in Colorectal Cancer
- (2011) Gordon Hutchins et al. JOURNAL OF CLINICAL ONCOLOGY
- Adjuvant Chemotherapy for Stage II Colon Cancer With Poor Prognostic Features
- (2011) Erin S. O'Connor et al. JOURNAL OF CLINICAL ONCOLOGY
- Capecitabine Plus Oxaliplatin Compared With Fluorouracil and Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer
- (2011) Daniel G. Haller et al. JOURNAL OF CLINICAL ONCOLOGY
- Primary Tumor Response to Preoperative Chemoradiation With or Without Oxaliplatin in Locally Advanced Rectal Cancer: Pathologic Results of the STAR-01 Randomized Phase III Trial
- (2011) Carlo Aschele et al. JOURNAL OF CLINICAL ONCOLOGY
- Predicting Chemotherapy Toxicity in Older Adults With Cancer: A Prospective Multicenter Study
- (2011) Arti Hurria et al. JOURNAL OF CLINICAL ONCOLOGY
- The BRAF V600E mutation is an independent prognostic factor for survival in stage II and stage III colon cancer patients
- (2010) A. Fariña-Sarasqueta et al. ANNALS OF ONCOLOGY
- Defective Mismatch Repair As a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon Cancer
- (2010) Daniel J. Sargent et al. JOURNAL OF CLINICAL ONCOLOGY
- Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group
- (2009) Olav Dahl et al. ACTA ONCOLOGICA
- Impact of Older Age on the Efficacy of Newer Adjuvant Chemotherapy Regimens in Colon Cancer, a Subgroup Analysis of a Meta-analysis: Practice Changing? Certainly Not; Hypothesis Generating? Perhaps
- (2009) M. Sitki Copur Clinical Colorectal Cancer
- Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial
- (2009) Thierry André et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of Age on Survival Benefit of Adjuvant Chemotherapy in Elderly Patients with Stage III Colon Cancer
- (2009) Ilene H. Zuckerman et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Is it deleterious to delay the start of adjuvant chemotherapy in colon cancer stage III?
- (2008) A. Berglund et al. ANNALS OF ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started